View transcript
<p><strong>As with any investment, your capital may be at risk.</strong></p>
<p> </p>
<p><strong>Bill Chater:</strong> The technologies available, that’s the broadest it’s ever been. Think of solar panels, batteries, semiconductors. It’s making it easier for companies to access these, to experiment with them, to create new products and services that can go on to transform end markets, and consumer expectations along with it. And that’s why we think this approach is more valid now than it’s ever been.</p>
<p> </p>
<p><strong>Alnylam</strong></p>
<p>So, when a company is based on a piece of science which has won the Nobel Prize, that’s a pretty good indication it’s doing something special. That was the case with Alnylam, a biotech business who has a singular approach to gene silencing. This is the most potent and powerful drug-discovery engine in the industry. You’re looking at treatments for Alzheimer’s, hypertension, diabetes, cardiometabolic disorders. Success here would be transformational not just for Alnylam, not just for its investors, but for all of those patients who need better treatments in these areas.</p>
<p> </p>
<p><strong>Axon</strong></p>
<p>In 1993, two of Rick Smith’s friends and classmates were shot and killed in a police incident. He went on to go and found Axon and made its corporate mission to protect life and make the bullet obsolete. Now, it’s perhaps best known by its originally eponymous product, the taser, but alongside that it has a growing and increasingly important business in the provision of smart sensors, bodycams and software for the collection, interpretation and storage of evidence. The combination of class-leading innovative hardware and interoperable software, once it’s in place, very hard for rivals to steal a march on it. And it can generate recurring, attractive cash flows from that model.</p>
<p> </p>
<p><strong>SpaceX</strong></p>
<p>Imagine humanity as a multi-planetary species. Sounds like science fiction, right? But that’s the mission of SpaceX, the private space technology and satellite communications company. The ability to reuse its rockets, that has led to a profound and important cost advantage compared to rivals. Alongside that, the satellite constellation Starlink, which is live now in 70 countries with 2.5 million subscribers. The next big unlock will be Starship. This is the rocket which is going to go to the moon. It’s going to go to Mars. Maybe even beyond. It’s going to open a variety of use cases. It’s really going to transform things.</p>
<p> </p>
<h3>Risk Factors</h3>
<p>The views expressed should not be considered as advice or a recommendation to buy, sell or hold a particular investment. They reflect opinion and should not be taken as statements of fact nor should any reliance be placed on them when making investment decisions.</p>
<p>This communication was produced and approved in September 2024 and has not been updated subsequently. It represents views held at the time of writing and may not reflect current thinking.</p>
<p><strong>Potential for Profit and Loss</strong> <br>All investment strategies have the potential for profit and loss, your or your clients’ capital may be at risk. Past performance is not a guide to future returns.</p>
<p>This communication contains information on investments which does not constitute independent research. Accordingly, it is not subject to the protections afforded to independent research, but is classified as advertising under Art 68 of the Financial Services Act (‘FinSA’) and Baillie Gifford and its staff may have dealt in the investments concerned.</p>
<p>All information is sourced from Baillie Gifford & Co and is current unless otherwise stated. </p>
<p>The images used in this communication are for illustrative purposes only.</p>
<p><strong>Important Information </strong></p>
<p>Baillie Gifford & Co and Baillie Gifford & Co Limited are authorised and regulated by the Financial Conduct Authority (FCA). Baillie Gifford & Co Limited is an Authorised Corporate Director of OEICs. </p>
<p>Baillie Gifford Overseas Limited provides investment management and advisory services to non-UK Professional/Institutional clients only. Baillie Gifford Overseas Limited is wholly owned by Baillie Gifford & Co. Baillie Gifford & Co and Baillie Gifford Overseas Limited are authorised and regulated by the FCA in the UK.</p>
<p>Persons resident or domiciled outside the UK should consult with their professional advisers as to whether they require any governmental or other consents in order to enable them to invest, and with their tax advisers for advice relevant to their own particular circumstances.</p>
<p><strong>Financial Intermediaries</strong></p>
<p>This communication is suitable for use of financial intermediaries. Financial intermediaries are solely responsible for any further distribution and Baillie Gifford takes no responsibility for the reliance on this document by any other person who did not receive this document directly from Baillie Gifford.</p>
